AIMS: Apolipoprotein C-III (ApoC-III) is well recognized as a main determinant of triglyceride (TG) plasma concentration and plays a crucial role in coronary artery disease (CAD). However, data on ApoC-III glycoforms are only sparse so far. The aim of this study was to quantify ApoC-III glycoforms in CAD patients and to assess their correlations with plasma lipids. METHODS: ApoC-III glycoforms were analysed by mass spectrometry in 55 subjects with clinically stable CAD (90.9% males, mean age 70.2±7.9 years) within the framework of the Verona Heart Study. RESULTS: Three different ApoC-III glycoforms were identified: non-sialylated (ApoC-III0), monosialylated (ApoC-III1), and disialylated isoforms (ApoC-III2). The analyses were performed on the relative proportion of ApoC-III glycoforms. ApoC-III0 correlated negatively with total ApoC-III concentration (R=-0.351;P=0.009), ApoC-III1 had a positive correlation (R=0.382;P=0.004), while ApoC-III2 did not have significant correlation. The different glycoforms showed different pattern of correlations with the other parameters of plasma lipid profile. ApoC-III0 was inversely correlated with TG (R=-0.421;P=0.001), total cholesterol (R=-0.314;P=0.020), LDL cholesterol (R=-0.317;P=0.018), ApoE (R=-0.434;P=0.001), and Apo B (R=-0.292;P=0.030), while ApoC-III1 was directly correlated with TG (R=0.438;P=0.001) ), total cholesterol (R=0.280;P=0.038), LDL cholesterol (R=0.337;P=0.012), ApoE (R=0.457;P=0.001), and ApoB (R=0.288;P=0.033). On the other hand, no significant correlation was found for ApoC-III2. The ApoC-III1/ApoC-III0 ratio was a significant predictor of both TG (β=0.201;P=0.025) and ApoE levels (β=0.270; P=0.016) in linear regression models adjusted for sex, age, and total ApoC-III concentration.CONCLUSIONS: ApoC-III glycoforms have heterogeneous correlations with plasma lipids in CAD patients, suggesting that they could have different metabolic properties and biological activities.

Apolipoprotein -CIII glycoforms correlate heterogeneously with plasma lipid profile in subjects with coronary artery disease

CHIARIELLO, CARMELA;CASTAGNA, Annalisa;MARTINELLI, Nicola;GUARINI, Patrizia;CECCONI, Daniela;OLIVIERI, Oliviero
2016

Abstract

AIMS: Apolipoprotein C-III (ApoC-III) is well recognized as a main determinant of triglyceride (TG) plasma concentration and plays a crucial role in coronary artery disease (CAD). However, data on ApoC-III glycoforms are only sparse so far. The aim of this study was to quantify ApoC-III glycoforms in CAD patients and to assess their correlations with plasma lipids. METHODS: ApoC-III glycoforms were analysed by mass spectrometry in 55 subjects with clinically stable CAD (90.9% males, mean age 70.2±7.9 years) within the framework of the Verona Heart Study. RESULTS: Three different ApoC-III glycoforms were identified: non-sialylated (ApoC-III0), monosialylated (ApoC-III1), and disialylated isoforms (ApoC-III2). The analyses were performed on the relative proportion of ApoC-III glycoforms. ApoC-III0 correlated negatively with total ApoC-III concentration (R=-0.351;P=0.009), ApoC-III1 had a positive correlation (R=0.382;P=0.004), while ApoC-III2 did not have significant correlation. The different glycoforms showed different pattern of correlations with the other parameters of plasma lipid profile. ApoC-III0 was inversely correlated with TG (R=-0.421;P=0.001), total cholesterol (R=-0.314;P=0.020), LDL cholesterol (R=-0.317;P=0.018), ApoE (R=-0.434;P=0.001), and Apo B (R=-0.292;P=0.030), while ApoC-III1 was directly correlated with TG (R=0.438;P=0.001) ), total cholesterol (R=0.280;P=0.038), LDL cholesterol (R=0.337;P=0.012), ApoE (R=0.457;P=0.001), and ApoB (R=0.288;P=0.033). On the other hand, no significant correlation was found for ApoC-III2. The ApoC-III1/ApoC-III0 ratio was a significant predictor of both TG (β=0.201;P=0.025) and ApoE levels (β=0.270; P=0.016) in linear regression models adjusted for sex, age, and total ApoC-III concentration.CONCLUSIONS: ApoC-III glycoforms have heterogeneous correlations with plasma lipids in CAD patients, suggesting that they could have different metabolic properties and biological activities.
Apolipoproteins, glycosylation, TG, cholesterol, PUFA, statins.
File in questo prodotto:
File Dimensione Formato  
poster EAS 2016 Carmela Chiariello.pdf

accesso aperto

Tipologia: Documento in Post-print
Licenza: Accesso ristretto
Dimensione 847.53 kB
Formato Adobe PDF
847.53 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/945516
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact